Digoxin, other inotropic agents, and ACE inhibitors are contraindicated in HOCM as they worsen the obstruction, though they may have a role in the end-stage dilated thin-walled HOCM hearts with impaired LV systolic function
BKKM is conducting further investigations into the matter, including verifying the claims and examining product details such as labelling compliance, ingredients used, manufacturing premises, importers, and local market distribution, the division said in a statement to Harian Metro today
Real-world data confirms patients maintaining GLP-1 therapy experience durable metabolic improvements and reduced disease incidence for type 2 diabetes and cardiovascular events
HEPATOLOGY 1998
The Tufts researchers, however, have uncovered a fourth receptor that could be added to the mix, potentially offering a more powerful and balanced approach to managing weight
There is no published human clinical trial of 5-Amino-1MQ